Global Peptide Therapy Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process.
LPI (LP Information)' newest research report, the “Peptide Therapy Industry Forecast” looks at past sales and reviews total world Peptide Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide Therapy sales for 2023 through 2029. With Peptide Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Therapy industry.
This Insight Report provides a comprehensive analysis of the global Peptide Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Peptide Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Therapy.
The global Peptide Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peptide Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peptide Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peptide Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peptide Therapy players cover Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Peptide Therapy market?
What factors are driving Peptide Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peptide Therapy market opportunities vary by end market size?
How does Peptide Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process.
LPI (LP Information)' newest research report, the “Peptide Therapy Industry Forecast” looks at past sales and reviews total world Peptide Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide Therapy sales for 2023 through 2029. With Peptide Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Therapy industry.
This Insight Report provides a comprehensive analysis of the global Peptide Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Peptide Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Therapy.
The global Peptide Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peptide Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peptide Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peptide Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peptide Therapy players cover Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Parenteral Route of Administration
- Mucosal Route of Administration
- Oral Route of Administration
- Transdermal Route of Administration
- Cancer
- Cardiovascular Diseases
- Gastrointestinal Disorders
- Metabolic Disorders
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- AstraZeneca
- Merck
- Ipsen
- Novo Nordisk
- Teva Pharmaceutical Industries
- Abbott Laboratories
- Sanofi
- J & J
- Novartis
- Takeda
- Ferring
- AbbVie
- Heinis
- Hemmo
- Emcure Pharmaceutical
- Cipla
- Gland Pharma
- Troikaa Pharmaceuticals
- Biological E
What is the 10-year outlook for the global Peptide Therapy market?
What factors are driving Peptide Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peptide Therapy market opportunities vary by end market size?
How does Peptide Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Peptide Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Peptide Therapy by Country/Region, 2018, 2022 & 2029
2.2 Peptide Therapy Segment by Type
2.2.1 Parenteral Route of Administration
2.2.2 Mucosal Route of Administration
2.2.3 Oral Route of Administration
2.2.4 Transdermal Route of Administration
2.3 Peptide Therapy Sales by Type
2.3.1 Global Peptide Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global Peptide Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Peptide Therapy Sale Price by Type (2018-2023)
2.4 Peptide Therapy Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Gastrointestinal Disorders
2.4.4 Metabolic Disorders
2.4.5 Others
2.5 Peptide Therapy Sales by Application
2.5.1 Global Peptide Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global Peptide Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Peptide Therapy Sale Price by Application (2018-2023)
3 GLOBAL PEPTIDE THERAPY BY COMPANY
3.1 Global Peptide Therapy Breakdown Data by Company
3.1.1 Global Peptide Therapy Annual Sales by Company (2018-2023)
3.1.2 Global Peptide Therapy Sales Market Share by Company (2018-2023)
3.2 Global Peptide Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global Peptide Therapy Revenue by Company (2018-2023)
3.2.2 Global Peptide Therapy Revenue Market Share by Company (2018-2023)
3.3 Global Peptide Therapy Sale Price by Company
3.4 Key Manufacturers Peptide Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peptide Therapy Product Location Distribution
3.4.2 Players Peptide Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEPTIDE THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Peptide Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global Peptide Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Peptide Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Peptide Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global Peptide Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Peptide Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Peptide Therapy Sales Growth
4.4 APAC Peptide Therapy Sales Growth
4.5 Europe Peptide Therapy Sales Growth
4.6 Middle East & Africa Peptide Therapy Sales Growth
5 AMERICAS
5.1 Americas Peptide Therapy Sales by Country
5.1.1 Americas Peptide Therapy Sales by Country (2018-2023)
5.1.2 Americas Peptide Therapy Revenue by Country (2018-2023)
5.2 Americas Peptide Therapy Sales by Type
5.3 Americas Peptide Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Therapy Sales by Region
6.1.1 APAC Peptide Therapy Sales by Region (2018-2023)
6.1.2 APAC Peptide Therapy Revenue by Region (2018-2023)
6.2 APAC Peptide Therapy Sales by Type
6.3 APAC Peptide Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peptide Therapy by Country
7.1.1 Europe Peptide Therapy Sales by Country (2018-2023)
7.1.2 Europe Peptide Therapy Revenue by Country (2018-2023)
7.2 Europe Peptide Therapy Sales by Type
7.3 Europe Peptide Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Therapy by Country
8.1.1 Middle East & Africa Peptide Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Peptide Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa Peptide Therapy Sales by Type
8.3 Middle East & Africa Peptide Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peptide Therapy
10.3 Manufacturing Process Analysis of Peptide Therapy
10.4 Industry Chain Structure of Peptide Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peptide Therapy Distributors
11.3 Peptide Therapy Customer
12 WORLD FORECAST REVIEW FOR PEPTIDE THERAPY BY GEOGRAPHIC REGION
12.1 Global Peptide Therapy Market Size Forecast by Region
12.1.1 Global Peptide Therapy Forecast by Region (2024-2029)
12.1.2 Global Peptide Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peptide Therapy Forecast by Type
12.7 Global Peptide Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Peptide Therapy Product Portfolios and Specifications
13.1.3 Eli Lilly Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Peptide Therapy Product Portfolios and Specifications
13.2.3 AstraZeneca Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Peptide Therapy Product Portfolios and Specifications
13.3.3 Merck Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Ipsen
13.4.1 Ipsen Company Information
13.4.2 Ipsen Peptide Therapy Product Portfolios and Specifications
13.4.3 Ipsen Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ipsen Main Business Overview
13.4.5 Ipsen Latest Developments
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Information
13.5.2 Novo Nordisk Peptide Therapy Product Portfolios and Specifications
13.5.3 Novo Nordisk Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novo Nordisk Main Business Overview
13.5.5 Novo Nordisk Latest Developments
13.6 Teva Pharmaceutical Industries
13.6.1 Teva Pharmaceutical Industries Company Information
13.6.2 Teva Pharmaceutical Industries Peptide Therapy Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Industries Main Business Overview
13.6.5 Teva Pharmaceutical Industries Latest Developments
13.7 Abbott Laboratories
13.7.1 Abbott Laboratories Company Information
13.7.2 Abbott Laboratories Peptide Therapy Product Portfolios and Specifications
13.7.3 Abbott Laboratories Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Laboratories Main Business Overview
13.7.5 Abbott Laboratories Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Peptide Therapy Product Portfolios and Specifications
13.8.3 Sanofi Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 J & J
13.9.1 J & J Company Information
13.9.2 J & J Peptide Therapy Product Portfolios and Specifications
13.9.3 J & J Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 J & J Main Business Overview
13.9.5 J & J Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Peptide Therapy Product Portfolios and Specifications
13.10.3 Novartis Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Peptide Therapy Product Portfolios and Specifications
13.11.3 Takeda Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
13.12 Ferring
13.12.1 Ferring Company Information
13.12.2 Ferring Peptide Therapy Product Portfolios and Specifications
13.12.3 Ferring Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ferring Main Business Overview
13.12.5 Ferring Latest Developments
13.13 AbbVie
13.13.1 AbbVie Company Information
13.13.2 AbbVie Peptide Therapy Product Portfolios and Specifications
13.13.3 AbbVie Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Main Business Overview
13.13.5 AbbVie Latest Developments
13.14 Heinis
13.14.1 Heinis Company Information
13.14.2 Heinis Peptide Therapy Product Portfolios and Specifications
13.14.3 Heinis Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Heinis Main Business Overview
13.14.5 Heinis Latest Developments
13.15 Hemmo
13.15.1 Hemmo Company Information
13.15.2 Hemmo Peptide Therapy Product Portfolios and Specifications
13.15.3 Hemmo Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hemmo Main Business Overview
13.15.5 Hemmo Latest Developments
13.16 Emcure Pharmaceutical
13.16.1 Emcure Pharmaceutical Company Information
13.16.2 Emcure Pharmaceutical Peptide Therapy Product Portfolios and Specifications
13.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Emcure Pharmaceutical Main Business Overview
13.16.5 Emcure Pharmaceutical Latest Developments
13.17 Cipla
13.17.1 Cipla Company Information
13.17.2 Cipla Peptide Therapy Product Portfolios and Specifications
13.17.3 Cipla Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Cipla Main Business Overview
13.17.5 Cipla Latest Developments
13.18 Gland Pharma
13.18.1 Gland Pharma Company Information
13.18.2 Gland Pharma Peptide Therapy Product Portfolios and Specifications
13.18.3 Gland Pharma Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Gland Pharma Main Business Overview
13.18.5 Gland Pharma Latest Developments
13.19 Troikaa Pharmaceuticals
13.19.1 Troikaa Pharmaceuticals Company Information
13.19.2 Troikaa Pharmaceuticals Peptide Therapy Product Portfolios and Specifications
13.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Troikaa Pharmaceuticals Main Business Overview
13.19.5 Troikaa Pharmaceuticals Latest Developments
13.20 Biological E
13.20.1 Biological E Company Information
13.20.2 Biological E Peptide Therapy Product Portfolios and Specifications
13.20.3 Biological E Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Biological E Main Business Overview
13.20.5 Biological E Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Peptide Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Peptide Therapy by Country/Region, 2018, 2022 & 2029
2.2 Peptide Therapy Segment by Type
2.2.1 Parenteral Route of Administration
2.2.2 Mucosal Route of Administration
2.2.3 Oral Route of Administration
2.2.4 Transdermal Route of Administration
2.3 Peptide Therapy Sales by Type
2.3.1 Global Peptide Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global Peptide Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Peptide Therapy Sale Price by Type (2018-2023)
2.4 Peptide Therapy Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Gastrointestinal Disorders
2.4.4 Metabolic Disorders
2.4.5 Others
2.5 Peptide Therapy Sales by Application
2.5.1 Global Peptide Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global Peptide Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Peptide Therapy Sale Price by Application (2018-2023)
3 GLOBAL PEPTIDE THERAPY BY COMPANY
3.1 Global Peptide Therapy Breakdown Data by Company
3.1.1 Global Peptide Therapy Annual Sales by Company (2018-2023)
3.1.2 Global Peptide Therapy Sales Market Share by Company (2018-2023)
3.2 Global Peptide Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global Peptide Therapy Revenue by Company (2018-2023)
3.2.2 Global Peptide Therapy Revenue Market Share by Company (2018-2023)
3.3 Global Peptide Therapy Sale Price by Company
3.4 Key Manufacturers Peptide Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peptide Therapy Product Location Distribution
3.4.2 Players Peptide Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEPTIDE THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Peptide Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global Peptide Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Peptide Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Peptide Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global Peptide Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Peptide Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Peptide Therapy Sales Growth
4.4 APAC Peptide Therapy Sales Growth
4.5 Europe Peptide Therapy Sales Growth
4.6 Middle East & Africa Peptide Therapy Sales Growth
5 AMERICAS
5.1 Americas Peptide Therapy Sales by Country
5.1.1 Americas Peptide Therapy Sales by Country (2018-2023)
5.1.2 Americas Peptide Therapy Revenue by Country (2018-2023)
5.2 Americas Peptide Therapy Sales by Type
5.3 Americas Peptide Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Therapy Sales by Region
6.1.1 APAC Peptide Therapy Sales by Region (2018-2023)
6.1.2 APAC Peptide Therapy Revenue by Region (2018-2023)
6.2 APAC Peptide Therapy Sales by Type
6.3 APAC Peptide Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peptide Therapy by Country
7.1.1 Europe Peptide Therapy Sales by Country (2018-2023)
7.1.2 Europe Peptide Therapy Revenue by Country (2018-2023)
7.2 Europe Peptide Therapy Sales by Type
7.3 Europe Peptide Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Therapy by Country
8.1.1 Middle East & Africa Peptide Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Peptide Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa Peptide Therapy Sales by Type
8.3 Middle East & Africa Peptide Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peptide Therapy
10.3 Manufacturing Process Analysis of Peptide Therapy
10.4 Industry Chain Structure of Peptide Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peptide Therapy Distributors
11.3 Peptide Therapy Customer
12 WORLD FORECAST REVIEW FOR PEPTIDE THERAPY BY GEOGRAPHIC REGION
12.1 Global Peptide Therapy Market Size Forecast by Region
12.1.1 Global Peptide Therapy Forecast by Region (2024-2029)
12.1.2 Global Peptide Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peptide Therapy Forecast by Type
12.7 Global Peptide Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Peptide Therapy Product Portfolios and Specifications
13.1.3 Eli Lilly Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Peptide Therapy Product Portfolios and Specifications
13.2.3 AstraZeneca Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Peptide Therapy Product Portfolios and Specifications
13.3.3 Merck Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Ipsen
13.4.1 Ipsen Company Information
13.4.2 Ipsen Peptide Therapy Product Portfolios and Specifications
13.4.3 Ipsen Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ipsen Main Business Overview
13.4.5 Ipsen Latest Developments
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Information
13.5.2 Novo Nordisk Peptide Therapy Product Portfolios and Specifications
13.5.3 Novo Nordisk Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novo Nordisk Main Business Overview
13.5.5 Novo Nordisk Latest Developments
13.6 Teva Pharmaceutical Industries
13.6.1 Teva Pharmaceutical Industries Company Information
13.6.2 Teva Pharmaceutical Industries Peptide Therapy Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Industries Main Business Overview
13.6.5 Teva Pharmaceutical Industries Latest Developments
13.7 Abbott Laboratories
13.7.1 Abbott Laboratories Company Information
13.7.2 Abbott Laboratories Peptide Therapy Product Portfolios and Specifications
13.7.3 Abbott Laboratories Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Laboratories Main Business Overview
13.7.5 Abbott Laboratories Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Peptide Therapy Product Portfolios and Specifications
13.8.3 Sanofi Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 J & J
13.9.1 J & J Company Information
13.9.2 J & J Peptide Therapy Product Portfolios and Specifications
13.9.3 J & J Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 J & J Main Business Overview
13.9.5 J & J Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Peptide Therapy Product Portfolios and Specifications
13.10.3 Novartis Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Peptide Therapy Product Portfolios and Specifications
13.11.3 Takeda Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
13.12 Ferring
13.12.1 Ferring Company Information
13.12.2 Ferring Peptide Therapy Product Portfolios and Specifications
13.12.3 Ferring Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ferring Main Business Overview
13.12.5 Ferring Latest Developments
13.13 AbbVie
13.13.1 AbbVie Company Information
13.13.2 AbbVie Peptide Therapy Product Portfolios and Specifications
13.13.3 AbbVie Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Main Business Overview
13.13.5 AbbVie Latest Developments
13.14 Heinis
13.14.1 Heinis Company Information
13.14.2 Heinis Peptide Therapy Product Portfolios and Specifications
13.14.3 Heinis Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Heinis Main Business Overview
13.14.5 Heinis Latest Developments
13.15 Hemmo
13.15.1 Hemmo Company Information
13.15.2 Hemmo Peptide Therapy Product Portfolios and Specifications
13.15.3 Hemmo Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hemmo Main Business Overview
13.15.5 Hemmo Latest Developments
13.16 Emcure Pharmaceutical
13.16.1 Emcure Pharmaceutical Company Information
13.16.2 Emcure Pharmaceutical Peptide Therapy Product Portfolios and Specifications
13.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Emcure Pharmaceutical Main Business Overview
13.16.5 Emcure Pharmaceutical Latest Developments
13.17 Cipla
13.17.1 Cipla Company Information
13.17.2 Cipla Peptide Therapy Product Portfolios and Specifications
13.17.3 Cipla Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Cipla Main Business Overview
13.17.5 Cipla Latest Developments
13.18 Gland Pharma
13.18.1 Gland Pharma Company Information
13.18.2 Gland Pharma Peptide Therapy Product Portfolios and Specifications
13.18.3 Gland Pharma Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Gland Pharma Main Business Overview
13.18.5 Gland Pharma Latest Developments
13.19 Troikaa Pharmaceuticals
13.19.1 Troikaa Pharmaceuticals Company Information
13.19.2 Troikaa Pharmaceuticals Peptide Therapy Product Portfolios and Specifications
13.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Troikaa Pharmaceuticals Main Business Overview
13.19.5 Troikaa Pharmaceuticals Latest Developments
13.20 Biological E
13.20.1 Biological E Company Information
13.20.2 Biological E Peptide Therapy Product Portfolios and Specifications
13.20.3 Biological E Peptide Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Biological E Main Business Overview
13.20.5 Biological E Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peptide Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Peptide Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Parenteral Route of Administration
Table 4. Major Players of Mucosal Route of Administration
Table 5. Major Players of Oral Route of Administration
Table 6. Major Players of Transdermal Route of Administration
Table 7. Global Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 8. Global Peptide Therapy Sales Market Share by Type (2018-2023)
Table 9. Global Peptide Therapy Revenue by Type (2018-2023) & ($ million)
Table 10. Global Peptide Therapy Revenue Market Share by Type (2018-2023)
Table 11. Global Peptide Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 13. Global Peptide Therapy Sales Market Share by Application (2018-2023)
Table 14. Global Peptide Therapy Revenue by Application (2018-2023)
Table 15. Global Peptide Therapy Revenue Market Share by Application (2018-2023)
Table 16. Global Peptide Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Peptide Therapy Sales by Company (2018-2023) & (K Units)
Table 18. Global Peptide Therapy Sales Market Share by Company (2018-2023)
Table 19. Global Peptide Therapy Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Peptide Therapy Revenue Market Share by Company (2018-2023)
Table 21. Global Peptide Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Peptide Therapy Producing Area Distribution and Sales Area
Table 23. Players Peptide Therapy Products Offered
Table 24. Peptide Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Peptide Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Peptide Therapy Sales Market Share Geographic Region (2018-2023)
Table 29. Global Peptide Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Peptide Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Peptide Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Peptide Therapy Sales Market Share by Country/Region (2018-2023)
Table 33. Global Peptide Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Peptide Therapy Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Peptide Therapy Sales by Country (2018-2023) & (K Units)
Table 36. Americas Peptide Therapy Sales Market Share by Country (2018-2023)
Table 37. Americas Peptide Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Peptide Therapy Revenue Market Share by Country (2018-2023)
Table 39. Americas Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 40. Americas Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 41. APAC Peptide Therapy Sales by Region (2018-2023) & (K Units)
Table 42. APAC Peptide Therapy Sales Market Share by Region (2018-2023)
Table 43. APAC Peptide Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Peptide Therapy Revenue Market Share by Region (2018-2023)
Table 45. APAC Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 46. APAC Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 47. Europe Peptide Therapy Sales by Country (2018-2023) & (K Units)
Table 48. Europe Peptide Therapy Sales Market Share by Country (2018-2023)
Table 49. Europe Peptide Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Peptide Therapy Revenue Market Share by Country (2018-2023)
Table 51. Europe Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 52. Europe Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Peptide Therapy Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Peptide Therapy Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Peptide Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Peptide Therapy Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Peptide Therapy
Table 60. Key Market Challenges & Risks of Peptide Therapy
Table 61. Key Industry Trends of Peptide Therapy
Table 62. Peptide Therapy Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Peptide Therapy Distributors List
Table 65. Peptide Therapy Customer List
Table 66. Global Peptide Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Peptide Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Peptide Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Peptide Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Peptide Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Peptide Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Peptide Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Peptide Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Peptide Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Peptide Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Peptide Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Peptide Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Peptide Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Peptide Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Eli Lilly Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 81. Eli Lilly Peptide Therapy Product Portfolios and Specifications
Table 82. Eli Lilly Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly Main Business
Table 84. Eli Lilly Latest Developments
Table 85. AstraZeneca Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Peptide Therapy Product Portfolios and Specifications
Table 87. AstraZeneca Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. Merck Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Peptide Therapy Product Portfolios and Specifications
Table 92. Merck Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Ipsen Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 96. Ipsen Peptide Therapy Product Portfolios and Specifications
Table 97. Ipsen Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Ipsen Main Business
Table 99. Ipsen Latest Developments
Table 100. Novo Nordisk Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 101. Novo Nordisk Peptide Therapy Product Portfolios and Specifications
Table 102. Novo Nordisk Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Novo Nordisk Main Business
Table 104. Novo Nordisk Latest Developments
Table 105. Teva Pharmaceutical Industries Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Industries Peptide Therapy Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Industries Main Business
Table 109. Teva Pharmaceutical Industries Latest Developments
Table 110. Abbott Laboratories Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 111. Abbott Laboratories Peptide Therapy Product Portfolios and Specifications
Table 112. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Abbott Laboratories Main Business
Table 114. Abbott Laboratories Latest Developments
Table 115. Sanofi Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 116. Sanofi Peptide Therapy Product Portfolios and Specifications
Table 117. Sanofi Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Sanofi Main Business
Table 119. Sanofi Latest Developments
Table 120. J & J Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 121. J & J Peptide Therapy Product Portfolios and Specifications
Table 122. J & J Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. J & J Main Business
Table 124. J & J Latest Developments
Table 125. Novartis Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 126. Novartis Peptide Therapy Product Portfolios and Specifications
Table 127. Novartis Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Novartis Main Business
Table 129. Novartis Latest Developments
Table 130. Takeda Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Peptide Therapy Product Portfolios and Specifications
Table 132. Takeda Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Takeda Main Business
Table 134. Takeda Latest Developments
Table 135. Ferring Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 136. Ferring Peptide Therapy Product Portfolios and Specifications
Table 137. Ferring Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Ferring Main Business
Table 139. Ferring Latest Developments
Table 140. AbbVie Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 141. AbbVie Peptide Therapy Product Portfolios and Specifications
Table 142. AbbVie Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. AbbVie Main Business
Table 144. AbbVie Latest Developments
Table 145. Heinis Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 146. Heinis Peptide Therapy Product Portfolios and Specifications
Table 147. Heinis Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Heinis Main Business
Table 149. Heinis Latest Developments
Table 150. Hemmo Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 151. Hemmo Peptide Therapy Product Portfolios and Specifications
Table 152. Hemmo Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Hemmo Main Business
Table 154. Hemmo Latest Developments
Table 155. Emcure Pharmaceutical Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 156. Emcure Pharmaceutical Peptide Therapy Product Portfolios and Specifications
Table 157. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Emcure Pharmaceutical Main Business
Table 159. Emcure Pharmaceutical Latest Developments
Table 160. Cipla Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 161. Cipla Peptide Therapy Product Portfolios and Specifications
Table 162. Cipla Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Cipla Main Business
Table 164. Cipla Latest Developments
Table 165. Gland Pharma Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 166. Gland Pharma Peptide Therapy Product Portfolios and Specifications
Table 167. Gland Pharma Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Gland Pharma Main Business
Table 169. Gland Pharma Latest Developments
Table 170. Troikaa Pharmaceuticals Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 171. Troikaa Pharmaceuticals Peptide Therapy Product Portfolios and Specifications
Table 172. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. Troikaa Pharmaceuticals Main Business
Table 174. Troikaa Pharmaceuticals Latest Developments
Table 175. Biological E Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 176. Biological E Peptide Therapy Product Portfolios and Specifications
Table 177. Biological E Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Biological E Main Business
Table 179. Biological E Latest Developments
Table 1. Peptide Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Peptide Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Parenteral Route of Administration
Table 4. Major Players of Mucosal Route of Administration
Table 5. Major Players of Oral Route of Administration
Table 6. Major Players of Transdermal Route of Administration
Table 7. Global Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 8. Global Peptide Therapy Sales Market Share by Type (2018-2023)
Table 9. Global Peptide Therapy Revenue by Type (2018-2023) & ($ million)
Table 10. Global Peptide Therapy Revenue Market Share by Type (2018-2023)
Table 11. Global Peptide Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 13. Global Peptide Therapy Sales Market Share by Application (2018-2023)
Table 14. Global Peptide Therapy Revenue by Application (2018-2023)
Table 15. Global Peptide Therapy Revenue Market Share by Application (2018-2023)
Table 16. Global Peptide Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Peptide Therapy Sales by Company (2018-2023) & (K Units)
Table 18. Global Peptide Therapy Sales Market Share by Company (2018-2023)
Table 19. Global Peptide Therapy Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Peptide Therapy Revenue Market Share by Company (2018-2023)
Table 21. Global Peptide Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Peptide Therapy Producing Area Distribution and Sales Area
Table 23. Players Peptide Therapy Products Offered
Table 24. Peptide Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Peptide Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Peptide Therapy Sales Market Share Geographic Region (2018-2023)
Table 29. Global Peptide Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Peptide Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Peptide Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Peptide Therapy Sales Market Share by Country/Region (2018-2023)
Table 33. Global Peptide Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Peptide Therapy Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Peptide Therapy Sales by Country (2018-2023) & (K Units)
Table 36. Americas Peptide Therapy Sales Market Share by Country (2018-2023)
Table 37. Americas Peptide Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Peptide Therapy Revenue Market Share by Country (2018-2023)
Table 39. Americas Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 40. Americas Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 41. APAC Peptide Therapy Sales by Region (2018-2023) & (K Units)
Table 42. APAC Peptide Therapy Sales Market Share by Region (2018-2023)
Table 43. APAC Peptide Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Peptide Therapy Revenue Market Share by Region (2018-2023)
Table 45. APAC Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 46. APAC Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 47. Europe Peptide Therapy Sales by Country (2018-2023) & (K Units)
Table 48. Europe Peptide Therapy Sales Market Share by Country (2018-2023)
Table 49. Europe Peptide Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Peptide Therapy Revenue Market Share by Country (2018-2023)
Table 51. Europe Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 52. Europe Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Peptide Therapy Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Peptide Therapy Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Peptide Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Peptide Therapy Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Peptide Therapy Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Peptide Therapy Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Peptide Therapy
Table 60. Key Market Challenges & Risks of Peptide Therapy
Table 61. Key Industry Trends of Peptide Therapy
Table 62. Peptide Therapy Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Peptide Therapy Distributors List
Table 65. Peptide Therapy Customer List
Table 66. Global Peptide Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Peptide Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Peptide Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Peptide Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Peptide Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Peptide Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Peptide Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Peptide Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Peptide Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Peptide Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Peptide Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Peptide Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Peptide Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Peptide Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Eli Lilly Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 81. Eli Lilly Peptide Therapy Product Portfolios and Specifications
Table 82. Eli Lilly Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly Main Business
Table 84. Eli Lilly Latest Developments
Table 85. AstraZeneca Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Peptide Therapy Product Portfolios and Specifications
Table 87. AstraZeneca Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. Merck Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Peptide Therapy Product Portfolios and Specifications
Table 92. Merck Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Ipsen Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 96. Ipsen Peptide Therapy Product Portfolios and Specifications
Table 97. Ipsen Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Ipsen Main Business
Table 99. Ipsen Latest Developments
Table 100. Novo Nordisk Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 101. Novo Nordisk Peptide Therapy Product Portfolios and Specifications
Table 102. Novo Nordisk Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Novo Nordisk Main Business
Table 104. Novo Nordisk Latest Developments
Table 105. Teva Pharmaceutical Industries Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Industries Peptide Therapy Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Industries Main Business
Table 109. Teva Pharmaceutical Industries Latest Developments
Table 110. Abbott Laboratories Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 111. Abbott Laboratories Peptide Therapy Product Portfolios and Specifications
Table 112. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Abbott Laboratories Main Business
Table 114. Abbott Laboratories Latest Developments
Table 115. Sanofi Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 116. Sanofi Peptide Therapy Product Portfolios and Specifications
Table 117. Sanofi Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Sanofi Main Business
Table 119. Sanofi Latest Developments
Table 120. J & J Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 121. J & J Peptide Therapy Product Portfolios and Specifications
Table 122. J & J Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. J & J Main Business
Table 124. J & J Latest Developments
Table 125. Novartis Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 126. Novartis Peptide Therapy Product Portfolios and Specifications
Table 127. Novartis Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Novartis Main Business
Table 129. Novartis Latest Developments
Table 130. Takeda Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Peptide Therapy Product Portfolios and Specifications
Table 132. Takeda Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Takeda Main Business
Table 134. Takeda Latest Developments
Table 135. Ferring Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 136. Ferring Peptide Therapy Product Portfolios and Specifications
Table 137. Ferring Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Ferring Main Business
Table 139. Ferring Latest Developments
Table 140. AbbVie Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 141. AbbVie Peptide Therapy Product Portfolios and Specifications
Table 142. AbbVie Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. AbbVie Main Business
Table 144. AbbVie Latest Developments
Table 145. Heinis Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 146. Heinis Peptide Therapy Product Portfolios and Specifications
Table 147. Heinis Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Heinis Main Business
Table 149. Heinis Latest Developments
Table 150. Hemmo Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 151. Hemmo Peptide Therapy Product Portfolios and Specifications
Table 152. Hemmo Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Hemmo Main Business
Table 154. Hemmo Latest Developments
Table 155. Emcure Pharmaceutical Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 156. Emcure Pharmaceutical Peptide Therapy Product Portfolios and Specifications
Table 157. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Emcure Pharmaceutical Main Business
Table 159. Emcure Pharmaceutical Latest Developments
Table 160. Cipla Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 161. Cipla Peptide Therapy Product Portfolios and Specifications
Table 162. Cipla Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Cipla Main Business
Table 164. Cipla Latest Developments
Table 165. Gland Pharma Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 166. Gland Pharma Peptide Therapy Product Portfolios and Specifications
Table 167. Gland Pharma Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Gland Pharma Main Business
Table 169. Gland Pharma Latest Developments
Table 170. Troikaa Pharmaceuticals Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 171. Troikaa Pharmaceuticals Peptide Therapy Product Portfolios and Specifications
Table 172. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. Troikaa Pharmaceuticals Main Business
Table 174. Troikaa Pharmaceuticals Latest Developments
Table 175. Biological E Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors
Table 176. Biological E Peptide Therapy Product Portfolios and Specifications
Table 177. Biological E Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Biological E Main Business
Table 179. Biological E Latest Developments
LIST OF FIGURES
Figure 1. Picture of Peptide Therapy
Figure 2. Peptide Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peptide Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Peptide Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Peptide Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Parenteral Route of Administration
Figure 10. Product Picture of Mucosal Route of Administration
Figure 11. Product Picture of Oral Route of Administration
Figure 12. Product Picture of Transdermal Route of Administration
Figure 13. Global Peptide Therapy Sales Market Share by Type in 2022
Figure 14. Global Peptide Therapy Revenue Market Share by Type (2018-2023)
Figure 15. Peptide Therapy Consumed in Cancer
Figure 16. Global Peptide Therapy Market: Cancer (2018-2023) & (K Units)
Figure 17. Peptide Therapy Consumed in Cardiovascular Diseases
Figure 18. Global Peptide Therapy Market: Cardiovascular Diseases (2018-2023) & (K Units)
Figure 19. Peptide Therapy Consumed in Gastrointestinal Disorders
Figure 20. Global Peptide Therapy Market: Gastrointestinal Disorders (2018-2023) & (K Units)
Figure 21. Peptide Therapy Consumed in Metabolic Disorders
Figure 22. Global Peptide Therapy Market: Metabolic Disorders (2018-2023) & (K Units)
Figure 23. Peptide Therapy Consumed in Others
Figure 24. Global Peptide Therapy Market: Others (2018-2023) & (K Units)
Figure 25. Global Peptide Therapy Sales Market Share by Application (2022)
Figure 26. Global Peptide Therapy Revenue Market Share by Application in 2022
Figure 27. Peptide Therapy Sales Market by Company in 2022 (K Units)
Figure 28. Global Peptide Therapy Sales Market Share by Company in 2022
Figure 29. Peptide Therapy Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Peptide Therapy Revenue Market Share by Company in 2022
Figure 31. Global Peptide Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Peptide Therapy Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Peptide Therapy Sales 2018-2023 (K Units)
Figure 34. Americas Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 35. APAC Peptide Therapy Sales 2018-2023 (K Units)
Figure 36. APAC Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 37. Europe Peptide Therapy Sales 2018-2023 (K Units)
Figure 38. Europe Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Peptide Therapy Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 41. Americas Peptide Therapy Sales Market Share by Country in 2022
Figure 42. Americas Peptide Therapy Revenue Market Share by Country in 2022
Figure 43. Americas Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 44. Americas Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 45. United States Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Peptide Therapy Sales Market Share by Region in 2022
Figure 50. APAC Peptide Therapy Revenue Market Share by Regions in 2022
Figure 51. APAC Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 52. APAC Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 53. China Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Peptide Therapy Sales Market Share by Country in 2022
Figure 61. Europe Peptide Therapy Revenue Market Share by Country in 2022
Figure 62. Europe Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 63. Europe Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 64. Germany Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Peptide Therapy Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Peptide Therapy Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 73. Egypt Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Peptide Therapy in 2022
Figure 79. Manufacturing Process Analysis of Peptide Therapy
Figure 80. Industry Chain Structure of Peptide Therapy
Figure 81. Channels of Distribution
Figure 82. Global Peptide Therapy Sales Market Forecast by Region (2024-2029)
Figure 83. Global Peptide Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Peptide Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Peptide Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Peptide Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Peptide Therapy Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Peptide Therapy
Figure 2. Peptide Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peptide Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Peptide Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Peptide Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Parenteral Route of Administration
Figure 10. Product Picture of Mucosal Route of Administration
Figure 11. Product Picture of Oral Route of Administration
Figure 12. Product Picture of Transdermal Route of Administration
Figure 13. Global Peptide Therapy Sales Market Share by Type in 2022
Figure 14. Global Peptide Therapy Revenue Market Share by Type (2018-2023)
Figure 15. Peptide Therapy Consumed in Cancer
Figure 16. Global Peptide Therapy Market: Cancer (2018-2023) & (K Units)
Figure 17. Peptide Therapy Consumed in Cardiovascular Diseases
Figure 18. Global Peptide Therapy Market: Cardiovascular Diseases (2018-2023) & (K Units)
Figure 19. Peptide Therapy Consumed in Gastrointestinal Disorders
Figure 20. Global Peptide Therapy Market: Gastrointestinal Disorders (2018-2023) & (K Units)
Figure 21. Peptide Therapy Consumed in Metabolic Disorders
Figure 22. Global Peptide Therapy Market: Metabolic Disorders (2018-2023) & (K Units)
Figure 23. Peptide Therapy Consumed in Others
Figure 24. Global Peptide Therapy Market: Others (2018-2023) & (K Units)
Figure 25. Global Peptide Therapy Sales Market Share by Application (2022)
Figure 26. Global Peptide Therapy Revenue Market Share by Application in 2022
Figure 27. Peptide Therapy Sales Market by Company in 2022 (K Units)
Figure 28. Global Peptide Therapy Sales Market Share by Company in 2022
Figure 29. Peptide Therapy Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Peptide Therapy Revenue Market Share by Company in 2022
Figure 31. Global Peptide Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Peptide Therapy Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Peptide Therapy Sales 2018-2023 (K Units)
Figure 34. Americas Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 35. APAC Peptide Therapy Sales 2018-2023 (K Units)
Figure 36. APAC Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 37. Europe Peptide Therapy Sales 2018-2023 (K Units)
Figure 38. Europe Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Peptide Therapy Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Peptide Therapy Revenue 2018-2023 ($ Millions)
Figure 41. Americas Peptide Therapy Sales Market Share by Country in 2022
Figure 42. Americas Peptide Therapy Revenue Market Share by Country in 2022
Figure 43. Americas Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 44. Americas Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 45. United States Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Peptide Therapy Sales Market Share by Region in 2022
Figure 50. APAC Peptide Therapy Revenue Market Share by Regions in 2022
Figure 51. APAC Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 52. APAC Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 53. China Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Peptide Therapy Sales Market Share by Country in 2022
Figure 61. Europe Peptide Therapy Revenue Market Share by Country in 2022
Figure 62. Europe Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 63. Europe Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 64. Germany Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Peptide Therapy Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Peptide Therapy Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Peptide Therapy Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Peptide Therapy Sales Market Share by Application (2018-2023)
Figure 73. Egypt Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Peptide Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Peptide Therapy in 2022
Figure 79. Manufacturing Process Analysis of Peptide Therapy
Figure 80. Industry Chain Structure of Peptide Therapy
Figure 81. Channels of Distribution
Figure 82. Global Peptide Therapy Sales Market Forecast by Region (2024-2029)
Figure 83. Global Peptide Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Peptide Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Peptide Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Peptide Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Peptide Therapy Revenue Market Share Forecast by Application (2024-2029)
